Events & Conferences

In this section, explore the key scientific events and conferences where Clinisciences takes center stage—whether as a sponsor or an active participant. From high-impact international congresses to focused expert symposia, our presence reflects our dedication to advancing research and connecting with the scientific community. These events are more than just dates on a calendar—they're opportunities to exchange ideas, showcase innovative tools, and stay at the forefront of scientific discovery. Join us where breakthroughs happen!

Webinar : Enzymatic Workflows for Protein Characterization

Webinar : Enzymatic Workflows for Protein Characterization

Explore an innovative integrated enzymatic workflow designed for the comprehensive structural characterization of therapeutic proteins, including monoclonal antibodies, biosimilars, and recombinant proteins. By leveraging the synergistic action of PNGase F, Trypsin MS Grade, and Carboxypeptidase B, this webinar provides a detailed demonstration of precise N-glycan profiling, peptide mapping with post-translational modification (PTM) identification, and accurate assessment of C-terminal heterogeneity—an orthogonal, multi-enzyme approach essential for mastering critical quality attributes and meeting stringent regulatory requirements (ICH Q6B, biosimilar comparability exercises). Register to gain in-depth insight into the scientific rationale, analytical interpretation, and practical implementation in biopharmaceutical development and quality control. 

Conference & School on Extracellular Vesicles and Nanoparticles

Conference & School on Extracellular Vesicles and Nanoparticles

CSEVP-2026, the Conference & School on Extracellular Vesicles and Nanoparticles, will take place in Frascati and Rome, Italy, from 16–20 February 2026, bringing together experts and early-career researchers to explore advances in EV and nanoparticle biology.

SIGNET 2026

SIGNET 2026

SIGNET 2026 brings together immunologists on 11 March 2026 in Perth for a one-day symposium featuring keynote talks, poster sessions, and networking to support collaboration in immunology.

STEMNet 2026

STEMNet 2026

Die STEMNet 2026, die vom 12. bis 13. März 2026 in Bologna stattfindet, wird Fortschritte in der Stammzellenforschung und translationalen Zelltherapie im Rahmen von wissenschaftlichen Sitzungen, Postern und Auszeichnungen für junge Forscher präsentieren.

SY-Stem

SY-Stem

Quimigen is proud to participate as an official sponsor of SY-Stem 2026, an international symposium dedicated to fostering the next generation of stem cell researchers. This annual scientific meeting brings together early-career scientists, emerging group leaders, and established experts to discuss the latest advances in stem cell biology in an interactive and collaborative setting

1st SIB Young Meeting

1st SIB Young Meeting

From 25–27 March 2026, the 1st SIB Young Meeting will be held in Abano Terme (Pd), Italy, offering young biochemists and molecular bioscientists a dedicated forum for networking, training, and discussion of emerging research topics.

From Bench to Leadership - A workshop for young PIs in biology

From Bench to Leadership - A workshop for young PIs in biology

The 2nd GBM Young Investigators Workshop, entitled “From Bench to Leadership,” will be held from 13–16 April 2026 at the University of Regensburg, Germany, and is dedicated to leadership and management training for early-career researchers in the life sciences.

39th AFH Congress

39th AFH Congress

The 39ᵉ Congrès AFH 2026 will take place in Nîmes, France, from 10–12 June 2026, bringing together histology and histotechnology professionals to explore the latest scientific advances, techniques, and laboratory innovations.

Press Release: Genexpath joins Quimigen Group

Press Release: Genexpath joins Quimigen Group

Quimigen strengthens its leadership in molecular biology and hemato-oncology with the strategic acquisition of Genexpath, a specialist in in vitro diagnostic solutions for lymphomas and sarcomas.

Press release : Oncomedics joins Quimigen Group

Press release : Oncomedics joins Quimigen Group

Quimigen Group, a European distributor of reagents and equipment for scientific research and medical diagnosis, has acquired Oncomedics, a French biotechnology company specialising in the personalisation of cancer treatments.